GSK, Sanofi and Merck Seek Further Inroads In India Industry
This article was originally published in PharmAsia News
Executive Summary
The strictly local pharmaceutical industry in India is expected to shrink this year as at least three companies consider international deals. U.K.-based GlaxoSmithKline is said to be interested in Piramal Healthcare, while Sanofi-Aventis of France and Merck KGaA of Germany consider other ties. GSK already had tipped its hand when it said it was stepping up its focus on emerging markets. Merck said it was interested in signing an Indian deal later this year as it negotiates other local ties, including at least two acquisitions. (Click here for more